The revenue in the mental health market in Brazil was forecast to continuously decrease between 2024 and 2029 by in total 104.8 million U.S. dollars (-13.52 percent). After the twelfth consecutive decreasing year, the indicator is estimated to reach 670.35 million U.S. dollars and therefore a new minimum in 2029.
Data provided by Statista Market Insights are estimates.
Mental health disorders are common illnesses found among people all over the world. These disorders are caused by a variety of genetic and environmental factors that cause imbalances in a person's physical and emotional behavior. Most mental health disorders can be treated with behavioral and psychotherapies. In some cases, however, medication is prescribed along with these treatments. The Mental Health market represents the market for the drugs that are used to treat various mild to serious mental health disorders. The market is divided into three markets that have been based on the disorders that are being treated. This includes depressive disorders, anxiety and related sleeping disorders, and different types of psychotic disorders.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Pfizer, Bristol-Myers Squibb, Johnson & Johnson, AbbVie, and Sumitomo pharma
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (June 25, 2024). Revenue of the mental health related medications market in Brazil from 2017 to 2029 (in million U.S. dollars) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1427458/indicator-revenue-mental-health-mental-health-market-brazil
Statista. "Revenue of the mental health related medications market in Brazil from 2017 to 2029 (in million U.S. dollars)." Chart. June 25, 2024. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1427458/indicator-revenue-mental-health-mental-health-market-brazil
Statista. (2024). Revenue of the mental health related medications market in Brazil from 2017 to 2029 (in million U.S. dollars). Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1427458/indicator-revenue-mental-health-mental-health-market-brazil
Statista. "Revenue of The Mental Health Related Medications Market in Brazil from 2017 to 2029 (in Million U.S. Dollars)." Statista, Statista Inc., 25 Jun 2024, https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1427458/indicator-revenue-mental-health-mental-health-market-brazil
Statista, Revenue of the mental health related medications market in Brazil from 2017 to 2029 (in million U.S. dollars) Statista, https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1427458/indicator-revenue-mental-health-mental-health-market-brazil (last visited November 10, 2024)
Revenue of the mental health related medications market in Brazil from 2017 to 2029 (in million U.S. dollars) [Graph], Statista, June 25, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1427458/indicator-revenue-mental-health-mental-health-market-brazil
